Chemical modification of the backbone at the cleavage site in the (6-13)-octapeptide of equine angiotensinogen resulted in greatly increased binding affinity and resistance to cleavage by renin. The D-His6-Tyr13 octapeptide analog containing the reduced bond -CH2-NH-instead of a peptide bond -CO-NH- at the Leu10-Leu11 linkage (H-77) was a powerful in vitro inhibitor of canine renin (IC50 = 24nM). It gave an IC50 of 1 microM against human renin and 0.6 microM against rat renin. In sodium-depleted conscious dogs, infusion of H-77 caused dose-related falls of plasma angiotensin I plasma angiotensin II concentration and mean arterial pressure; the minimum effective dose was 0.1 mg . kg-1 hr-1. Similar infusions of H-77 in chronically catheterized rats have no effect on blood pressure or plasma angiotensin II concentration. Thus, the in vitro effect of H-77 as an inhibitor of renin in dog, human, and rat plasma was paralleled by its action in the whole animal.
[1]
E. Haber,et al.
Competitive inhibitors of renin.
,
1973,
Acta physiologica latino americana.
[2]
K. Tatsuo,et al.
Peptide inhibitors of renin angiotensinogen reaction system.
,
1973
.
[3]
L. Skeggs,et al.
KINETICS OF THE REACTION OF RENIN WITH NINE SYNTHETIC PEPTIDE SUBSTRATES
,
1968,
The Journal of experimental medicine.
[4]
K. Hiwada,et al.
Peptide Inhibitors of the Renin–Angiotensin System
,
1968,
Nature.
[5]
L. Skeggs,et al.
THE PREPARATION, PURIFICATION, AND AMINO ACID SEQUENCE OF A POLYPEPTIDE RENIN SUBSTRATE
,
1957,
The Journal of experimental medicine.